QTTB · Q32 Bio Inc.
$15.10
-0.28 (-1.82%)
At close · Jul 24
Market Cap
$256.89M
Shares
16.96M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$53.74M
FY2025
Net Income
$29.82M
+162.5%
FY2025
Operating Margin
31.45%
FY2025
Diluted EPS
$2.42
+136.8%
FY2025
Operating Cash Flow
-$33.54M
+50.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| — | $53.74M | $0 | $1.16M | $3.21M | $33.97M | $2.7M | $1.67M | $3.68M | |
| $1.23M | $1.06M | $2.83M | — | — | — | — | — | — | |
| $15.25M | $19.16M | $48.14M | $62M | $98.35M | $93.09M | $100.39M | $89.4M | $47.95M | |
| $17.08M | $17.68M | $17.96M | $31.26M | $38.14M | $36.84M | $32.57M | $22.21M | $17.3M | |
| — | — | — | $10.28M | — | — | — | — | — | |
| $32.33M | $36.84M | $66.1M | $102.59M | $136.49M | $129.92M | $132.97M | $111.61M | $65.25M | |
| $21.41M | $16.9M | -$66.1M | -$101.43M | -$133.28M | -$95.95M | -$130.26M | -$109.94M | -$61.56M | |
| — | 31.45% | — | -8774.13% | -4154.64% | -282.44% | -4820.98% | -6599.22% | -1671.12% | |
| $11.84M | $12.92M | $20.02M | $14.35M | $134.48M | $185K | $1.57M | $6.03M | $4.35M | |
| — | $0 | -$1.63M | — | — | — | — | — | — | |
| — | $29.82M | -$46.09M | -$87.08M | $1.2M | — | — | — | — | |
| $0 | $0 | $21K | $0 | $715K | $0 | $0 | $0 | $0 | |
| -$7.61M | $29.82M | -$47.73M | -$112.96M | -$5.01M | -$95.76M | -$128.69M | -$103.92M | -$57.22M | |
| — | 55.49% | — | -9771.71% | -156.02% | -281.9% | -4762.92% | -6237.45% | -1553.07% | |
| $3.45M | $29.82K | -$47.73K | — | — | — | — | — | — | |
| — | $29.82M | -$47.73M | -$112.56M | -$5.4M | -$95.77M | -$128.88M | -$103.66M | -$57.22M | |
| USD/shares | — | $2.42 | -$5.12 | -$35.10 | -$1.62 | — | — | — | — |
| USD/shares | — | $2.42 | -$6.58 | -$35.10 | -$1.62 | — | — | — | — |
| shares | — | 12.3M | 9.32M | 3.21M | 3.19M | 3.07M | 2.55M | 2.34M | 1.59M |
| shares | — | 12.31M | 9.66M | 3.21M | 3.19M | 3.07M | 2.55M | 2.34M | 1.59M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.41×
EV/EBIT
—
Biotechnology median 26.60×
P/E (TTM)
5.45×
Biotechnology median 7.07×